Citations

Mayo Clinic

Showing 10 of 108599 citations.

Cardiac Resynchronisation with Conduction System Pacing
Ezzeddine, Fatima M. , Leon, Isaac G., Cha, Yong‐Mei , Ezzeddine, Fatima

Arrhythmia & Electrophysiology Review | August 14, 2023 | Volume: 12 | Issue: No issue available | Pages: No page available

10.15420/aer.2023.03 | PMID 37654672 Get It

To date, biventricular pacing (BiVP) has been the standard pacing modality for cardiac resynchronisation therapy. However, it is non-physiological, with the activation spreading between the left ventricular epicardium and right ventricular endocardium. Up to one-third of patients with heart failure who are eligible for cardiac resynchronisation therapy do not derive benefit from BiVP. Conduction system pacing (CSP), which includes His bundle pacing and left bundle branch area pacing, has emerged as an alternative to BiVP for cardiac resynchronisation. There is mounting evidence supporting the benefits of CSP in achieving synchronous ventricular activation and repolarisation. The aim of this review is to summarise the current options and outcomes of CSP when used for cardiac resynchronisation in patients with heart failure.
Enhancing diversity, equity, inclusion, and accessibility in eosinophilic gastrointestinal disease research: the consortium for eosinophilic gastrointestinal disease researchers’ journey
Chehade, Mirna , Furuta, Glenn T. , Abonia, J. Pablo , Aceves, Seema S. , Bose, Paroma , Dellon, Evan S. , Eickel, Grant, Gupta, Sandeep K. , Hiremath, Girish , Howard, Amari, Kesh, Susamita, Khoury, Paneez , Kocher, Kendra, Kodroff, Ellyn, Kyle, Shay, Mak, NaDea , McCoy, D. E., Mehta, Pooja , Menard‐Katcher, Paul , Paliana, Ally, Sable, Kathleen, Schmitt, Cara, Scott, Melissa, Strobel, Mary Jo, Zicarelli, Amy, Muir, Amanda B. , Wright, Benjamin L. , Bailey, Dominique D., Wright, Benjamin L , Klion, Amy D. , Collins, Margaret H. , Davis, Carla McGuire , Falk, Gary W. , Jensen, Elizabeth T. , McCoy, Dawn, Mukkada, Vincent A. , Rothenberg, Marc E. , Spergel, Jonathan M. , Wechsler, Joshua B , Yang, Guang‐Yu

Therapeutic Advances in Rare Disease | August 14, 2023 | Volume: 4 | Issue: No issue available | Pages: No page available

10.1177/26330040231180895 | PMID 37588777 Get It

In response to the social inequities that exist in health care, the NIH-funded Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) recently formed a diversity committee to examine systemic racism and implicit bias in the care and research of eosinophilic gastrointestinal diseases (EGIDs). Herein, we describe our process, highlighting milestones and issues addressed since the committee’s inception, which we hope will inspire other researchers to enhance diversity, equity, inclusion, and accessibility (DEIA) in their fields. Our journey began by establishing mission and vision statements to define the purpose of the committee. Regular discussion of diversity-related topics was incorporated into existing meetings and web-based materials were shared. This was followed by educational initiatives, including establishing a library of relevant publications and a speaker series to address DEIA topics. We then established a research agenda focused on the following actionable items: (1) to define what is known about the demographics of EGIDs by systematic review of population-based studies; (2) to develop a practical tool for reporting participant demographics to reduce bias in EGID literature; (3) to examine health disparities in the care of individuals with eosinophilic esophagitis who present to the emergency department with an esophageal food impaction; (4) to examine how access to a gastroenterologist affects the conclusions of published research examining the prevalence of pediatric eosinophilic esophagitis; and (5) to develop a model for examining the dimensions of diversity, and provide a framework for CEGIR’s ongoing projects and data capture. In addition to promoting consciousness of DEIA, this initiative has fostered inclusivity among CEGIR members and will continue to inspire positive changes in EGID care and research.
Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation study
Constantinescu, Andrei‐Emil , Bull, Caroline J. , Burrows, Kimberley , Buchanan, Daniel D. , D’Amato, Mauro , Pai, Rish K. , White, Emily , Timpson, Nicholas J. , Huyghe, Jeroen R. , Vincent, Emma E. , White, Emily , Buchanan, Daniel D , Moreno, Victor , Murphy, Neil , D'Amato, Mauro , Bull, Caroline J , Vincent, Emma E , Jones, Nicholas , Mitchell, Ruth E. , Dimou, Niki , Bezieau, Stéphane , Brenner, Hermann , Jenkins, Mark A. , Moreno, Vı́ctor , Um, Caroline Y. , Murphy, Neil , Gunter, Marc J.

International Journal of Cancer | August 14, 2023 | Volume: 154 | Issue: 1 | Pages: 94-103

10.1002/ijc.34691 | PMID 37578112 Get It

Abstract Observational studies have suggested a protective role for eosinophils in colorectal cancer (CRC) development and implicated neutrophils, but the causal relationships remain unclear. Here, we aimed to estimate the causal effect of circulating white blood cell (WBC) counts (N = ~550 000) for basophils, eosinophils, monocytes, lymphocytes and neutrophils on CRC risk (N = 52 775 cases and 45 940 controls) using Mendelian randomisation (MR). For comparison, we also examined this relationship using individual‐level data from UK Biobank (4043 incident CRC cases and 332 773 controls) in a longitudinal cohort analysis. The inverse‐variance weighted (IVW) MR analysis suggested a protective effect of increased basophil count and eosinophil count on CRC risk [OR per 1‐SD increase: 0.88, 95% CI: 0.78‐0.99, P = .04; OR: 0.93, 95% CI: 0.88‐0.98, P = .01]. The protective effect of eosinophils remained [OR per 1‐SD increase: 0.88, 95% CI: 0.80‐0.97, P = .01] following adjustments for all other WBC subtypes, to account for genetic correlation between the traits, using multivariable MR. A protective effect of increased lymphocyte count on CRC risk was also found [OR: 0.84, 95% CI: 0.76‐0.93, P = 6.70e‐4] following adjustment. Consistent with MR results, a protective effect for eosinophils in the cohort analysis in the fully adjusted model [RR per 1‐SD increase: 0.96, 95% CI: 0.93‐0.99, P = .02] and following adjustment for the other WBC subtypes [RR: 0.96, 95% CI: 0.93‐0.99, P = .001] was observed. Our study implicates peripheral blood immune cells, in particular eosinophils and lymphocytes, in CRC development, highlighting a need for mechanistic studies to interrogate these relationships.
Vascular multiple sclerosis: addressing the pathogenesis, genetics, pro-angiogenic factors, and vascular abnormalities, along with the role of vascular intervention
Shree, Anagha , Das, Soumyajit , Inban, Pugazhendi , Ghosh, Shankhaneel , Senthil, Arihant , Gurav, Jaiprakash , Kundu, Mrinmoy , Marsool, Mohammed Dheyaa Marsool , Gadam, Srikanth , Marsool, Ali Dheyaa Marsool , Vora, Neel , Hussin, Omniat Amir, Marsool, Mohammed Dheyaa , Gadam, Srikanth , Prajjwal, Priyadarshi

Annals of Medicine & Surgery | August 14, 2023 | Volume: 85 | Issue: 10 | Pages: 4928-4938

10.1097/ms9.0000000000001177 | PMID 37811110 Get It

Dysfunction in the epithelium, breakdown of the blood–brain barrier, and consequent leukocyte and T-cell infiltration into the central nervous system define Vascular Multiple Sclerosis. Multiple sclerosis (MS) affects around 2.5 million individuals worldwide, is the leading cause of neurological impairment in young adults, and can have a variety of progressions and consequences. Despite significant discoveries in immunology and molecular biology, the root cause of MS is still not fully understood, as do the immunological triggers and causative pathways. Recent research into vascular anomalies associated with MS suggests that a vascular component may be pivotal to the etiology of MS, and there can be actually a completely new entity in the already available classification of MS, which can be called ‘vascular multiple sclerosis’. Unlike the usual other causes of MS, vascular MS is not dependent on autoimmune pathophysiologic mechanisms, instead, it is caused due to the blood vessels pathology. This review aims to thoroughly analyze existing information and updates about the scattered available findings of genetics, pro-angiogenetic factors, and vascular abnormalities in this important spectrum, the vascular facets of MS.
Ectopic primary ductal breast carcinoma of the vulva: a case report and literature review
Zahra, O.S. , Nabulsi, Dalia, Alhamwi, Aya, Chahin, Maya, alani, Wael Raghid, Yousef, Diaa, Kanbour, Ilda, Kurdi, Bashar, Mansour, Marah , Zahra, Orgwan, Yousef, Diaa, Kurdi, Bashar, Deeb, Ahmad Mohammad

Annals of Medicine & Surgery | August 14, 2023 | Volume: 85 | Issue: 10 | Pages: 5138-5144

10.1097/ms9.0000000000001160 | PMID 37811111 Get It

Background: Ectopic breast tissue (EBT) is normally found along the rudimentary mammary line, which is located from the axilla to the inguinal region and disappears during embryogenesis. Up to 6% of females around the world suffer from EBT. EBT cancer is rare, with only a few reports in the literature. The diagnosis, and treatment of these rare cases can be very difficult and complex. Case presentation: The authors report an interesting case of a 74-year-old female patient with a vulvar lump located on the mons pubis associated with ulceration, pain, and size increase. The histopathological study demonstrated an invasive ductal carcinoma grade 2 arising from EBT in the vulva. Within 4 months of follow-up, the patient’s condition was stable. Clinical discussion and conclusions: Throughout this paper, the authors aim to highlight the diagnostic and therapeutic challenges since there are no current guidelines for treatment for such cases. Furthermore, this article describes this rare disease and includes surgical details, difficulties, diagnostic methods, and treatment options.
Sex differences in clinical characteristics and outcomes associated with alcoholic hepatitis
Pemmasani, Gayatri , Tremaine, William J., Aswath, Ganesh, Sapkota, Bishnu, Karagozian, Raffi, John, Savio, Kumar, Vishnu Charan Suresh

European Journal of Gastroenterology & Hepatology | August 14, 2023 | Volume: 35 | Issue: 10 | Pages: 1192-1196

10.1097/meg.0000000000002612 | PMID 37577797 Get It

Background Alcohol-associated liver disease is increasing among females with an earlier onset and more severe disease at lower levels of exposure. However, there is paucity of literature regarding sex differences related to alcoholic hepatitis. Methods Hospitalized patients with alcoholic hepatitis were selected from the US Nationwide readmissions database 2019. In this cohort, we evaluated sex differences in baseline comorbidities, alcoholic hepatitis related complications and mortality. A subset of patients with alcoholic hepatitis who were hospitalized between January and June 2019 were identified to study sex differences in 6 month readmission rate, mortality during readmission, and composite of mortality during index hospitalization or readmission. Results Among 112 790 patients with alcoholic hepatitis, 33.3% were female. Female patients were younger [48 (38–57) vs. 49 (39–58) years; both P < 0.001] but had higher rates of important medical and mental-health related comorbidities. Compared with males, females had higher rates of hepatic encephalopathy (11.5% vs. 10.1; P < 0.001), ascites (27.9% vs. 22.5%; P < 0.001), portal hypertension (18.5% vs. 16.4%; P < 0.001), cirrhosis (37.3% vs. 31.9%; P < 0.001), weight loss (19.0% vs. 14.5%; P < 0.001), hepatorenal syndrome (4.4% vs. 3.8%; P < 0.001), spontaneous bacterial peritonitis (1.9% vs. 1.7%; P = 0.026), sepsis (11.1% vs. 9.5%; P < 0.001), and blood transfusion (12.9% vs. 8.7%; P < 0.001). Females had a similar in-hospital mortality rate (4.3%) compared to males (4.1%; P = 0.202; adjusted odds ratio (OR) 1.02, 95% CI (cardiac index) 0.89–1.15; P = 0.994). In the subset of patients (N = 58 688), females had a higher 6-month readmission rate (48.9% vs. 44.9%; adjusted OR 1.12 (1.06–1.18); P < 0.001), mortality during readmission (4.4% vs. 3.2%; OR 1.23 (1.08–1.40); P < 0.01), and composite of mortality during index hospitalization or readmission (8.7% vs. 7.2%; OR 1.15 (1.04–1.27); P < 0.01). Conclusion Compared to their male counterparts, females with alcoholic hepatitis were generally younger but had higher rates of comorbidities, alcoholic hepatitis related complications, rehospitalizations and associated mortality. The greater risks of alcohol-associated liver dysfunction in females indicate the need for more aggressive management.
Endovascular treatment outcomes of vertebrobasilar junction aneurysms: Systematic review and meta-analysis
Şenol, Yiğit Can , Kobeissi, Hassan , Orscelik, Atakan , Bilgin, Cem , Ghozy, Sherief , Kallmes, David F. , Kadirvel, Ramanathan , Arul, Santhosh , Kallmes, David F , Kadirvel, Ram , Ghozy, Sherief , Kobeissi, Hassan , Orscelik, Atakan , Senol, Yigit Can , Bilgin, Cem

Interventional Neuroradiology | August 14, 2023 | Volume: 32 | Issue: 3 | Pages: 804-811

10.1177/15910199231194687 | PMID 37574971 Get It

Background Vertebrobasilar junction (VBJ) aneurysms represent a relatively rare and often anatomically complex subgroup of saccular aneurysms. This systematic review and meta-analysis aimed to assess the safety and efficacy of endovascular treatment (EVT) of VBJ aneurysms. Methods PubMed, Web of Science, Ovid Medline, Ovid Embase, and Scopus were searched from inception to 20 December 2022. We included primary studies assessing the long-term clinical and angiographic outcomes for VBJ aneurysms treated with endovascular techniques. We excluded surgically managed studies. All data were analyzed using R software version 4.2.1. We calculated pooled prevalence rates and their corresponding 95% confidence intervals (CI). Results In this meta-analysis, a total of 76 VBJ aneurysms from seven studies were included for quantitative analysis. The results showed that the rate of adequate occlusion (complete + near complete occlusion) was 94.1% (95% CI = 76.71–98.71), and the rate of complete occlusion was 77.7% (95% CI = 63.07–87.65). A modified Rankin Scale (mRS) score of 0–2 was achieved in 93.9% of patients (95% CI = 67.65–99.14). The mortality rate was found to be 5.9% (95% CI = 0.97–28.55), and the retreatment rate was 4.6% (95% CI = 1.50–13.36). The overall ischemic complication rate was 4.7% (95% CI = 0.73–25.4), while the overall hemorrhagic complication rate was 4.6% (95% CI = 1.5–13.36). Conclusions The treatment of VBJ aneurysms with EVT is effective in achieving curative treatment and is associated with good clinical outcomes and low mortality rates. These findings provide important insights into the clinical and angiographic outcomes and the complication rates of EVT for VBJ aneurysms.
Mayo Clinic’s journey in transforming employee tuition assistance in response to labor challenges
Bormann, Misun L., Hahn, Huh‐Jung , Fraser, Cathy H., Anderson, Ashley R.

The CASE Journal | August 14, 2023 | Volume: 20 | Issue: 3 | Pages: 565-582

10.1108/tcj-01-2023-0006 Get It

Research methodology The information used in the case study was obtained from secondary sources, such as internal documents, reports, news, and organization websites. Three of the four authors played a hands-on role in the case. Case overview/synopsis The COVID-19 pandemic exacerbated the global challenge of hiring and retaining health-care workers. To address its own challenges, Mayo Clinic decided to fundamentally transform its 30-year-old tuition assistance program: from a model centered on the premise that tuition assistance was an employee benefit for professional development purposes, to one that was more driven to meet the business needs of the employer by preparing internal talent for important roles throughout the institution. Herein, this case study first describes how the COVID-19 pandemic impacted health-care organizations like Mayo Clinic. Next, this study provides details on the original employee tuition assistance program, and then, focuses on the reasons for its need to be changed. Afterward, this study introduces the new tuition assistance programs. Finally, this study follows with examples of how both Mayo Clinic and its employees navigated through initial challenges, such as resistance to change and lack of engagement. In sum, this case study provides critical insight into designing workforce education programs that provide professional development for meeting the workforce needs of the organization. Complexity academic level This case can be used as teaching material in relevant undergraduate- and MBA-level courses, such as human resource management, human resource development and compensation and benefits. This case allows students to critically analyze workforce education programs (e.g. tuition assistance programs) and to plan how to strategically align those with the workforce needs of the organization.
Imaging of Fontan-Associated Liver Disease
Brown, Mark J. F. , Kolbe, Amy B. , Hull, Nathan C. , Hilscher, Moira , Kamath, Patrick S. , Yalon, Mariana , Gu, Chris N., Amawi, Ali Dean Tahboub , Wells, Michael , Brown, Mark J., Venkatesh, Sudhakar K.

Journal of Computer Assisted Tomography | August 14, 2023 | Volume: 48 | Issue: 1 | Pages: 1-11

10.1097/rct.0000000000001533 | PMID 37574655 Get It

Abstract The Fontan procedure is the definitive treatment for patients with single-ventricle physiology. Surgical advances have led to a growing number of patients surviving into adulthood. Fontan-associated liver disease (FALD) encompasses a spectrum of pathologic liver changes that occur secondary to altered physiology including congestion, fibrosis, and the development of liver masses. Assessment of FALD is difficult and relies on using imaging alongside of clinical, laboratory, and pathology information. Ultrasound, computed tomography, and magnetic resonance imaging are capable of demonstrating physiologic and hepatic parenchymal abnormalities commonly seen in FALD. Several novel imaging techniques including magnetic resonance elastography are under study for use as biomarkers for FALD progression. Imaging has a central role in detection and characterization of liver masses as benign or malignant. Benign FNH-like masses are commonly encountered; however, these can display atypical features and be mistaken for hepatocellular carcinoma (HCC). Fontan patients are at elevated risk for HCC, which is a feared complication and has a poor prognosis in this population. While imaging screening for HCC is widely advocated, no consensus has been reached regarding an optimal surveillance regimen.
Monitoring Ca19‐9 during pancreatic cyst surveillance: Better safe than sorry?
Perri, Giampaolo , Vege, Santhi Swaroop , Marchegiani, Giovanni , Marchegiani, Giovanni , Perri, Giampaolo

United European Gastroenterology Journal | August 13, 2023 | Volume: 11 | Issue: 7 | Pages: 599-600

10.1002/ueg2.12449 | PMID 37573577 Get It